Global metabolic profiling for the study of alcohol-related disorders

Bioanalysis

Volumn 6, Issue 1, 2014, Pages 59-77

  Gika, Helen G ^a   Wilson, Ian D ^b  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BIOLOGICAL MARKER;

ALCOHOL RELATED DISORDER; ALCOHOLISM; CLINICAL RESEARCH; DISEASE MARKER; DISEASE MODEL; HUMAN; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLIC DISORDER; METABOLIC PROFILING; METABOLOMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PLASMA; REVIEW; SERUM; TISSUES; URINE;

ALCOHOL-RELATED DISORDERS; ANIMALS; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EICOSANOIC ACIDS; ETHANOL; GLUCURONATES; HUMANS; INDOLES; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; METABOLOME; MICE; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SULFURIC ACID ESTERS;

EID: 84890950341     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.301     Document Type: Review

References (47)

1. Zakhari S, Li T-K. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 46(6), 2032-2039 (2007).
2. Laposata EA, Lange LG. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 231(4737), 497-499(1986).
3. Jaakonmaki PI, Knox KL, Horning EC, Horning MG. The characterization by gas-liquid chromatography of ethyl b-d-glucurosiduronic acid as a metabolite of ethanol in rat and man. Eur. J. Pharmacol. 1, 63-70 (1967).
4. Schmitt G, Aderjan R, Keller T, Wu M. Ethyl glucuronide: an unusual ethanol metabolite in humans. Synthesis, analytical data, and determination in serum and urine. J. Anal Toxicol. 19(2), 91-94 (1995).
5. Bicker W, Lämmerhofer M, Keller T, Schuhmacher R, Krska R, Lindner W. Validated method for the determination of the ethanol consumption markers ethyl glucuronide, ethyl phosphate, and ethyl sulfate in human urine by reversed-phase/weak anion exchange liquid chromatography-tandem mass spectrometry. Anal. Chem. 78(16), 5884-5892 (2006).
6. Dresen S, Weinmann W, Wurst FM. Forensic confirmatory analysis of ethyl sulfate -a new marker for alcohol consumption -by liquid-chromatography/ electrospray ionization/tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 15(11), 1644-1648 (2004).
7. Politi L, Morini L, Leone F, Polettini A. Ethyl glucuronide in hair: is it a reliable marker of chronic high levels of alcohol consumption? Addiction 101(10), 1408-1412 (2006).
8. Laposata M. Fatty acid ethyl esters: short-term and long-term serum markers of ethanol intake. Clin. Chem. 43(8 Pt 2), 1527-1534 (1997).
9. Varga A, Hansson P, Lundqvist C, Alling C. Phosphatidylethanol in blood as a marker of ethanol consumption in healthy volunteers: comparison with other markers. Alcohol Clin. Exp. Res. 22(8), 1832-1837 (1998).
10. Guo QM, Zakhari S. Commentary: systems biology and its relevance to alcohol research. Alcohol Res. Health 31(1), 5-11 (2008).
11. Lenz EM, Wilson ID. Analytical strategies in metabonomics. J. Proteome Res. 6(2), 443-458 (2007).
12. Theodoridis G, Gika HG, Wilson ID. Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies. Mass Spectrom. Rev. 30(5), 884-906 (2011).
13. Wilson ID, Nicholson JK, Castro-Perez J et al. High resolution 'Ultra Performance' liquid chromatography coupled to oa-TOF mass spectrometry as a tool for differential metabolic pathway profiling in functional genomic studies. J. Proteome Res. 4(2), 591-598 (2005).
14. Beckonert O, Keun HC, Ebbels TMD et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat. Protoc. 2(11), 2692-2703 (2007).
15. Want EJ, Wilson ID, Gika H et al. Global metabolic profiling procedures for urine using UPLC-MS. Nat. Protoc. 5(6), 1005-1018 (2010).
16. Gika H, Theodoridis G. Sample preparation prior to the LC-MS-based metabolomics/metabonomics of blood-derived samples. Bioanalysis 3(14), 1647-1661 (2011).
17. Lin CY, Wu H, Tjeerdema RS, Viant MR. Evaluation of metabolite extraction strategies from tissue samples using NMR. Metabolomics 3(1), 55-67 (2007).
18. Dunn WB, Broadhurst D, Begley P et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc. 6(7), 1060-1083 (2011).
19. Harrigan GG, Maguire G, Boros L. Metabolomics in alcohol research and drug development. Alcohol Res. Health 31(1), 26-35 (2008).
20. Tsukamoto H, French SW, Benson N et al. Severe and progressive steatosis and focal necrosis in rat liver induced by continuous intragastric infusion of ethanol and low fat diet. Hepatology 5(2), 224-232 (1985).
21. Wilson JS, Colley PW, Sosula L, Pirola RC, Chapman BA, Somer JB. Alcohol causes a fatty pancreas. a rat model of ethanol-induced pancreatic steatosis. Alcohol. Clin. Exp. Res. 6(1), 117-121 (1982).
22. Rashbastep J, Turro NJ, Cederbaum AI. Increased NADPH-and NADH-dependent production of superoxide and hydroxyl radical by microsomes after chronic ethanol treatment. Arch. Biochem. Biophys. 300(1), 401-408 (1993).
23. Lieber CS. The metabolism of alcohol. Sci. Am. 234(3), 25-33 (1976).
24. Bondy SC. Ethanol toxicity and oxidative stress. Toxicol. Lett. 63(3), 231-241 (1992).
25. Wang X, Lv H, Sun H et al. Metabolic urinary profiling of alcohol hepatotoxicity and intervention effects of Yin Chen Hao Tang in rats using ultra-performance liquid chromatography/electrospray ionization quadruple time-of-flight mass spectrometry. J. Pharm. Biomed. Anal. 48(4), 1161-1168 (2008).
26. Manna SK, Patterson AD, Yang Q et al. Identification of noninvasive biomarkers for alcohol-induced liver disease using urinary metabolomics and the Ppara-null mouse. J. Proteome Res. 9(8), 4176-4188 (2010).
27. Manna SK, Patterson AD, Yang Q et al. UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model. J. Proteome Res. 10(9), 4120-4133 (2011).
28. Loftus N, Barnes A, Ashton S et al. Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis. J. Proteome Res. 10(2), 705-713 (2011).
29. Li S, Liu H, Jin Y, Lin S, Cai Z, Jiang Y. Metabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in mice. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 879(24), 2369-2375 (2011).
30. Gika HG, Ji C, Theodoridis GA, Michopoulos F, Kaplowitz N, Wilson ID. Investigation of chronic alcohol consumption in rodents via ultra-high- performance liquid chromatography-mass spectrometry based metabolite profiling. J. Chromatogr. A 1259, 128-137 (2012).
31. Shi X, Yao D, Chen C. Identification of N-acetyltaurine as a novel metabolite of ethanol through metabolomics-guided biochemical analysis. J. Biol. Chem. 287(9), 6336-6349 (2012).
32. Xie G, Zhong W, Zheng X et al. Chronic ethanol consumption alters mammalian gastrointestinal content metabolites. J. Proteome Res. 12(7), 3297-3306 (2013).
33. Lian J, Liu W, Hao S et al. A serum metabonomic study on the difference between alcohol-and HBV-induced liver cirrhosis by ultraperformance liquid chromatography coupled to mass spectrometry plus quadrupole time-of-flight mass spectrometry. Chin. Med. J. 124(9), 1367-1373 (2011).
34. Nicholas PC, Kim D, Crews FT, Macdonald JM. 1H NMR-based metabolomic analysis of liver, serum, and brain following ethanol administration in rats. Chem. Res. Toxicol. 21(2), 408-420 (2008).
35. Bradford BU, O'Connell TM, Han J et al. Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease. Toxicol. Appl. Pharmacol. 232(2), 236-243 (2008).
36. Masuo Y, Imai T, Shibato J et al. Omic analyses unravels global molecular changes in the brain and liver of a rat model for chronic Sake (Japanese alcoholic beverage) intake. Electrophoresis 30(8), 1259-1275 (2009).
37. Fernando H, Kondraganti S, Bhopale KK et al. 1H and 31P NMR Lipidome of Ethanol-Induced Fatty Liver. Alcohol. Clin. Exp. Res. 34(11), 1937-1947 (2010).
38. Fernando H, Bhopale KK, Kondraganti S, Kaphalia BS, Shakeel Ansari GA. Lipidomic changes in rat liver after long-term exposure to ethanol. Toxicol. Appl. Pharmacol. 255(2), 127-137 (2011).
39. Vázquez-Fresno R, Llorach R, Alcaro F et al. (1)H-NMR-based metabolomic analysis of the effect of moderate wine consumption on subjects with cardiovascular risk factors. Electrophoresis 33(15), 2345-2354 (2012).
40. Yoseph BP, Breed E, Overgaard CE et al. Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis. PLoS ONE 8(5), e62792 (2013).
41. Gao X, Zhao A, Zhou M et al. GC/MS-based urinary metabolomics reveals systematic differences in metabolism and ethanol response between Sprague-Dawley and Wistar rats. Metabolomics 7(3), 363-374 (2011).
42. Obernier JA, Bouldin TW, Crews FT. Binge Ethanol Exposure in Adult Rats Causes Necrotic Cell Death. Alcohol. Clin. Exp. Res. 26(4), 547-557 (2002).
43. Simon JA, Fong J, Bemert JT, Browner WS. Relation of smoking and alcohol consumption to serum fatty acids. Am. J. Epidemiol. 144(4), 325-334 (1996).
44. Nakajima T, Kamijo Y, Tanaka N et al. Peroxisome proliferator-activated receptor alpha protects against alcohol-induced liver damage. Hepatology 40(4), 972-980 (2004).
45. Lieber CS, DeCarli LM. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 162(3856), 917-918 (1968).
46. Mutlu EA, Gillevet PM, Rangwala H et al. Colonic microbiome is altered in alcoholism. Am. J. Physiol. Gastrointest. Liver Physiol. 302(9), G966-G978 (2012).
47. The Telegraph. £3bn Cost of Alcohol to NHS Every Year.www.telegraph.co.uk/health/healthnews/5561217/3bn-cost-of-alcohol-to-NHS- every-year.html